EDGAR Filing Documents for 0001193125-13-328105

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-13-328105

Filing Date

2013-08-09

Accepted

2013-08-09 08:08:43

Documents

Period of Report

2013-06-30

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	d558254d10q.htm	10-Q	765033
2	EX-10.1	d558254dex101.htm	EX-10.1	80569
3	EX-12	d558254dex12.htm	EX-12	36398
4	EX-31.1	d558254dex311.htm	EX-31.1	9878
5	EX-31.2	d558254dex312.htm	EX-31.2	9874
6	EX-32.1	d558254dex321.htm	EX-32.1	4081
7	EX-32.2	d558254dex322.htm	EX-32.2	4116
	Complete submission text file	0001193125-13-328105.txt		5732195

Data Files

Seq	Description	Document	Type	Size
8	XBRL INSTANCE DOCUMENT	alny-20130630.xml	EX-101.INS	644191
9	XBRL TAXONOMY EXTENSION SCHEMA	alny-20130630.xsd	EX-101.SCH	29764
10	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	alny-20130630_cal.xml	EX-101.CAL	38913
11	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	alny-20130630_def.xml	EX-101.DEF	149732
12	XBRL TAXONOMY EXTENSION LABEL LINKBASE	alny-20130630_lab.xml	EX-101.LAB	242335
13	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	alny-20130630_pre.xml	EX-101.PRE	172180

Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142

Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200

ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50743 | Film No.: 131024528
SIC: 2834 Pharmaceutical Preparations